FibroBiologics (FBLG) Revenue & Revenue Breakdown
FibroBiologics Revenue Highlights
00
FibroBiologics Revenue by Period
FibroBiologics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | - |
FibroBiologics generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
FibroBiologics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-06-30 | - | 100.00% |
| 2025-03-31 | - | -100.00% |
| 2024-12-31 | $554.00K | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | - |
FibroBiologics generated - in revenue during Q2 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
FibroBiologics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| DARE | Daré Bioscience | $9.78M | $25.43K |
| PULM | Pulmatrix | $7.81M | - |
| ANL | Adlai Nortye Ltd. American Depositary Shares | $5.00M | $2.50M |
| LEXX | Lexaria Bioscience | $464.28K | $174.00K |
| EDSA | Edesa Biotech | - | - |
| ASBP | Aspire Biopharma | - | - |
| AIMD | Ainos | - | $106.21K |
| NXTC | NextCure | - | - |
| PALI | Palisade Bio | - | - |
| FBLG | FibroBiologics | - | - |